Causeway Therapeutics   Report issue

For profit Phase 1
Founded: Glasgow United Kingdom (2015)

Organization Overview

First Clinical Trial
2020
NCT04670289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Causeway Therapeutics

Active Ingredients

Drugs in Phase 1 Trials (1)

tenomir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tennis Elbow (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1